We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SHPHF market cap is 606.45M. The company's latest EPS is CNY -0.2052 and P/E is -0.29.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 2.92B | 2.89B | 2.47B | 3.29B | 2.38B |
| Operating Income | 1.71B | -2.54B | 281.49M | 127.31M | -2.02B |
| Net Income | 1.62B | -2.75B | 473.38M | 416.51M | -1.91B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 15.44B | 12.57B | 13.04B | 14.5B | 12.14B |
| Total Liabilities | 2.67B | 2.63B | 3.1B | 5.35B | 6.5B |
| Total Equity | 12.77B | 9.94B | 9.95B | 9.15B | 5.64B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 1.79B | 1.42B | 227.13M | 665.29M | 46.49M |
| Investing | 822.87M | 551.97M | -924.78M | -337.57M | -1.66B |
| Financing | -132.67M | -167.53M | 184.54M | 750.66M | -238.93M |
| Market Cap | 606.45M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 0.24 |
| Price to Cash Ratio | 0.15 |
| Price to Book Ratio | 0.1 |
| Dividend Yield | - |
| Shares Outstanding | 9.33B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 10k |
| 52 Week Change | -31.58% |
| 52 Week High | 0.12 |
| 52 Week Low | 0.045 |
| Spread (Intraday) | 0.06 (61.38%) |
| Company Name | Sihuan Pharmaceutical Holdings Group Ltd (PK) |
| Address |
clarendon house hamilton HM1022 |
| Website | https://www.sihuanpharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
